tiprankstipranks
uniQure N.V. (CH:UQ1)
NASDAQ:UQ1
Switzerland Market
UQ1
uniQure
RESEARCH TOOLSreports

uniQure (UQ1) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

UQ1 Analyst Ratings

Strong Buy
11Ratings
Strong Buy
10 Buy
1 Hold
0 Sell
Based on 11 analysts giving stock ratings to
uniQure
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

UQ1 Stock 12 Month Forecast

Average Price Target

$53.62
Based on 11 Wall Street analysts offering 12 month price targets for uniQure in the last 3 months. The average price target is $53.62 with a high forecast of $76.79 and a low forecast of $29.91. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$76.79Average Price Target$53.62Lowest Price Target$29.91
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on CH:UQ1
Patrick Trucchio
H.C. Wainwright
H.C. Wainwright
CHF40.42→CHF64.67
Buy
―
Reiterated
06/29/26
uniQure price target raised to $80 from $50 at H.C. WainwrightuniQure price target raised to $80 from $50 at H.C. Wainwright
Mizuho Securities Analyst forecast on CH:UQ1
Uy Ear
Mizuho Securities
Mizuho Securities
CHF28.29→CHF54.97
Buy
―
Reiterated
06/24/26
Analysts Are Bullish on These Healthcare Stocks: Ionis Pharmaceuticals (IONS), uniQure (QURE)
Barclays Analyst forecast on CH:UQ1
Eliana Merle
Barclays
Barclays
CHF20.21→CHF52.54
Buy
―
Upgraded
06/22/26
Positive Report for uniQure (QURE) from Barclays
Stifel Nicolaus Analyst forecast on CH:UQ1
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
CHF22.63→CHF57.39
Buy
―
Reiterated
06/21/26
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE)
RBC Capital Analyst forecast on CH:UQ1
Luca Issi
RBC Capital
RBC Capital
CHF28.29→CHF52.54
Buy
―
Reiterated
06/18/26
uniQure price target raised to $65 from $35 at RBC CapitaluniQure price target raised to $65 from $35 at RBC Capital
Leerink Partners Analyst forecast on CH:UQ1
Joseph Schwartz
Leerink Partners
Leerink Partners
CHF29.1→CHF56.58
Buy
―
Reiterated
06/17/26
Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)
TD Cowen Analyst forecast on CH:UQ1
Joseph Thome
TD Cowen
TD Cowen
―
Buy
―
Reiterated
06/17/26
TD Cowen Sticks to Their Buy Rating for uniQure (QURE)
Cantor Fitzgerald Analyst forecast on CH:UQ1
Kristen Kluska
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Upgraded
06/17/26
uniQure upgraded to Overweight from Neutral at Cantor FitzgeralduniQure upgraded to Overweight from Neutral at Cantor Fitzgerald
Goldman Sachs Analyst forecast on CH:UQ1
Salveen Richter
Goldman Sachs
Goldman Sachs
CHF11.32→CHF37.18
Hold
―
Assigned
06/17/26
uniQure price target raised to $46 from $14 at Goldman SachsuniQure price target raised to $46 from $14 at Goldman Sachs
Guggenheim Analyst forecast on CH:UQ1
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
CHF76.79
Buy
―
Reiterated
05/05/26
Guggenheim Sticks to Their Buy Rating for uniQure (QURE)
Chardan Capital Analyst forecast on CH:UQ1
Daniil Gataulin
Chardan Capital
Chardan Capital
CHF29.91
Buy
―
Reiterated
05/05/26
Chardan Capital Remains a Buy on uniQure (QURE)
Wells Fargo Analyst forecast on CH:UQ1
Yanan Zhu
Wells Fargo
Wells Fargo
CHF12.13→CHF48.5
Buy
―
Upgraded
03/09/26
uniQure upgraded to Overweight from Equal Weight at Wells FargouniQure upgraded to Overweight from Equal Weight at Wells Fargo
Wolfe Research Analyst forecast on CH:UQ1
Rudy Li
Wolfe Research
Wolfe Research
―
Hold
―
Initiated
02/23/26
uniQure initiated with a Peer Perform at Wolfe ResearchuniQure initiated with a Peer Perform at Wolfe Research
William Blair Analyst forecast on CH:UQ1
Sami Corwin
William Blair
William Blair
―
Hold
―
Reiterated
02/06/26
Balanced Risk/Reward at uniQure: Early Promise for AMT-191 Offset by Regulatory and Competitive Uncertainty Around AMT-130
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on CH:UQ1
Patrick Trucchio
H.C. Wainwright
H.C. Wainwright
CHF40.42→CHF64.67
Buy
―
Reiterated
06/29/26
uniQure price target raised to $80 from $50 at H.C. WainwrightuniQure price target raised to $80 from $50 at H.C. Wainwright
Mizuho Securities Analyst forecast on CH:UQ1
Uy Ear
Mizuho Securities
Mizuho Securities
CHF28.29→CHF54.97
Buy
―
Reiterated
06/24/26
Analysts Are Bullish on These Healthcare Stocks: Ionis Pharmaceuticals (IONS), uniQure (QURE)
Barclays Analyst forecast on CH:UQ1
Eliana Merle
Barclays
Barclays
CHF20.21→CHF52.54
Buy
―
Upgraded
06/22/26
Positive Report for uniQure (QURE) from Barclays
Stifel Nicolaus Analyst forecast on CH:UQ1
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
CHF22.63→CHF57.39
Buy
―
Reiterated
06/21/26
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE)
RBC Capital Analyst forecast on CH:UQ1
Luca Issi
RBC Capital
RBC Capital
CHF28.29→CHF52.54
Buy
―
Reiterated
06/18/26
uniQure price target raised to $65 from $35 at RBC CapitaluniQure price target raised to $65 from $35 at RBC Capital
Leerink Partners Analyst forecast on CH:UQ1
Joseph Schwartz
Leerink Partners
Leerink Partners
CHF29.1→CHF56.58
Buy
―
Reiterated
06/17/26
Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)
TD Cowen Analyst forecast on CH:UQ1
Joseph Thome
TD Cowen
TD Cowen
―
Buy
―
Reiterated
06/17/26
TD Cowen Sticks to Their Buy Rating for uniQure (QURE)
Cantor Fitzgerald Analyst forecast on CH:UQ1
Kristen Kluska
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Upgraded
06/17/26
uniQure upgraded to Overweight from Neutral at Cantor FitzgeralduniQure upgraded to Overweight from Neutral at Cantor Fitzgerald
Goldman Sachs Analyst forecast on CH:UQ1
Salveen Richter
Goldman Sachs
Goldman Sachs
CHF11.32→CHF37.18
Hold
―
Assigned
06/17/26
uniQure price target raised to $46 from $14 at Goldman SachsuniQure price target raised to $46 from $14 at Goldman Sachs
Guggenheim Analyst forecast on CH:UQ1
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
CHF76.79
Buy
―
Reiterated
05/05/26
Guggenheim Sticks to Their Buy Rating for uniQure (QURE)
Chardan Capital Analyst forecast on CH:UQ1
Daniil Gataulin
Chardan Capital
Chardan Capital
CHF29.91
Buy
―
Reiterated
05/05/26
Chardan Capital Remains a Buy on uniQure (QURE)
Wells Fargo Analyst forecast on CH:UQ1
Yanan Zhu
Wells Fargo
Wells Fargo
CHF12.13→CHF48.5
Buy
―
Upgraded
03/09/26
uniQure upgraded to Overweight from Equal Weight at Wells FargouniQure upgraded to Overweight from Equal Weight at Wells Fargo
Wolfe Research Analyst forecast on CH:UQ1
Rudy Li
Wolfe Research
Wolfe Research
―
Hold
―
Initiated
02/23/26
uniQure initiated with a Peer Perform at Wolfe ResearchuniQure initiated with a Peer Perform at Wolfe Research
William Blair Analyst forecast on CH:UQ1
Sami Corwin
William Blair
William Blair
―
Hold
―
Reiterated
02/06/26
Balanced Risk/Reward at uniQure: Early Promise for AMT-191 Offset by Regulatory and Competitive Uncertainty Around AMT-130
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering uniQure

3 Months
Joseph ThomeTD Cowen
Success Rate
13/22 ratings generated profit
59%
Average Return
+40.79%
Copying Joseph Thome's trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +40.79% per trade.
1 Year
Patrick TrucchioH.C. Wainwright
Success Rate
17/20 ratings generated profit
85%
Average Return
+97.84%
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 85.00% of your transactions generating a profit, with an average return of +97.84% per trade.
2 Years
Patrick TrucchioH.C. Wainwright
Success Rate
18/20 ratings generated profit
90%
Average Return
+214.92%
Copying Patrick Trucchio's trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +214.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UQ1 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
13
13
16
10
7
Buy
4
4
4
10
10
Hold
10
10
10
4
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
27
27
30
24
20
In the current month, UQ1 has received 17 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. UQ1 average Analyst price target in the past 3 months is 53.62.
Each month's total comprises the sum of three months' worth of ratings.

UQ1 Financial Forecast

UQ1 Earnings Forecast

Next quarter’s earnings estimate for UQ1 is -$0.67 with a range of -$0.74 to -$0.62. The previous quarter’s EPS was -$0.69. UQ1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year UQ1 has Performed in-line its overall industry.
Next quarter’s earnings estimate for UQ1 is -$0.67 with a range of -$0.74 to -$0.62. The previous quarter’s EPS was -$0.69. UQ1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year UQ1 has Performed in-line its overall industry.

UQ1 Sales Forecast

Next quarter’s sales forecast for UQ1 is $4.41M with a range of $1.86M to $8.10M. The previous quarter’s sales results were $2.89M. UQ1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year UQ1 has Performed in-line its overall industry.
Next quarter’s sales forecast for UQ1 is $4.41M with a range of $1.86M to $8.10M. The previous quarter’s sales results were $2.89M. UQ1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year UQ1 has Performed in-line its overall industry.

UQ1 Stock Forecast FAQ

What is CH:UQ1’s average 12-month price target, according to analysts?
Based on analyst ratings, uniQure N.V.’s 12-month average price target is 53.62.
    What is CH:UQ1’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:UQ1, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is uniQure N.V. a Buy, Sell or Hold?
        uniQure N.V. has a consensus rating of Strong Buy, which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.
          What is uniQure N.V.’s share price target?
          The average share price target for uniQure N.V. is 53.62. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $76.79 ,and the lowest forecast is $29.91. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about uniQure N.V.?
            uniQure N.V.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
              How can I buy shares of uniQure N.V.?
              To buy shares of CH:UQ1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.